• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Magnesium oxide and tocolysis. Our clinical experience and comparison with beta-mimetic (isoxusprine) therapy].

作者信息

Andreassi S, Teso A

机构信息

Divisione di Ostetrica e Ginecologia, Ospedale di Colleferro.

出版信息

Riv Eur Sci Med Farmacol. 1992 Sep-Oct;14(5):309-12.

PMID:1364063
Abstract

The authors propose the use of oral Magnesium Oxide in the quantity of 200 mg every 3-4 hours for the tocolytic treatment of the pre-term pain, once intravenous tocolysis has decreased or stopped uterine activity (since it has considerably more rapid effect). This treatment constitutes a valid alternative to the use of Beta Mimetic agents in all cases where their use is contraindicated. In the present study, we followed one heterogeneous group of 130 patients, suffering from premature labor hospitalized in our department. After decreasing the uterine contractions by intravenous isossuprine, sixty patients were subsequently treated with magnesium Oxide, fifty with oral isossisuprine, twenty with a simple antispasmodic and the remaining constituted the control group. The percentage of pre-term births has been almost the same in the first two groups (around 17%). The percentage of the patients who exhibited side effects of Beta Mimetic was 30-40%, against 2% of the patients treated with Magnesium Oxide. The intensity of the symptoms was however so slight in the patients treated with Magnesium Oxide, that it failed to disturb the compliance of the patients which allowed to continue the therapy for the necessary period.

摘要

相似文献

1
[Magnesium oxide and tocolysis. Our clinical experience and comparison with beta-mimetic (isoxusprine) therapy].
Riv Eur Sci Med Farmacol. 1992 Sep-Oct;14(5):309-12.
2
Magnesium sulfate and beta-mimetic dual-agent tocolysis in preterm labor after single-agent failure.单药治疗失败后,硫酸镁与β-拟似剂联合用药用于早产的宫缩抑制治疗
J Reprod Med. 1985 Aug;30(8):583-7.
3
[Tocolysis with the beta-adrenomimetic Partusisten in premature labor].使用β-肾上腺素能激动剂Partusisten治疗早产的宫缩抑制
Akush Ginekol (Sofiia). 1997;36(2):9-10.
4
Arg16 homozygosity of the beta2-adrenergic receptor improves the outcome after beta2-agonist tocolysis for preterm labor.β2-肾上腺素能受体的精氨酸16纯合性可改善β2-激动剂用于早产保胎治疗后的结局。
Clin Pharmacol Ther. 2005 Dec;78(6):656-63. doi: 10.1016/j.clpt.2005.08.021.
5
A comparative study between nifedipine and isoxsuprine in the suppression of preterm labour.硝苯地平与异克舒令抑制早产的比较研究。
Kathmandu Univ Med J (KUMJ). 2003 Apr-Jun;1(2):85-90.
6
[The importance of betamimetics and magnesium for the outcome of pregnancy: I. Reduction of intrauterine growth retardation, premature rupture of membranes and premature birth after supplemental magnesium therapy].β-拟交感神经药和镁对妊娠结局的重要性:I. 补充镁治疗后减少宫内生长受限、胎膜早破和早产
Z Geburtshilfe Perinatol. 1983 May-Jun;187(3):127-37.
7
[Tocolysis, use of beta-sympatomimetics for threatening preterm delivery: a critical review].[宫缩抑制,使用β-拟交感神经药治疗先兆早产:一项批判性综述]
J Gynecol Obstet Biol Reprod (Paris). 2001 May;30(3):221-30.
8
[Good sense and nonsense in tocolysis].[宫缩抑制中的合理与不合理之处]
Zentralbl Gynakol. 1995;117(6):300-3.
9
A prospective randomized comparison of oral terbutaline and magnesium oxide for the maintenance of tocolysis.口服特布他林与氧化镁用于维持宫缩抑制的前瞻性随机对照研究。
Am J Obstet Gynecol. 1990 Sep;163(3):879-82. doi: 10.1016/0002-9378(90)91087-s.
10
Oral magnesium for tocolysis: a comparison of magnesium gluconate and enteric-coated magnesium chloride.口服镁用于保胎:葡萄糖酸镁与肠溶氯化镁的比较
J Miss State Med Assoc. 1998 May;39(5):180-2.